Moreover, elevated HMMR expression associates with poor prognosis in a variety of cancers, such as breast cancer [68], colorectal cancer [69], stomach cancer [70], endometrial cancer [71], prostate cancer [72], and multiple myeloma [73]. This evidence concerns the gene HMMR and plasma cell myeloma.